Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Celestica (CLS) EBT (2024 - 2025)

Celestica (CLS) has disclosed EBT for 2 consecutive years, with $301.3 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 59.0% to $301.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $983.2 million, a 84.74% increase, with the full-year FY2025 number at $983.2 million, up 84.74% from a year prior.
  • EBT was $301.3 million for Q4 2025 at Celestica, down from $310.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $310.9 million in Q3 2025 to a low of $105.2 million in Q1 2024.